When Will We Be Transhuman? We can at least pretend to know where it is we want humanity to go.
Ivabradine reportedly improves heart rate variability in MVD-affected dogs with enlargement. They report finding that "the results revealed that chronic administration of ivabradine significantly decreased HR, BP, and RPP without adverse effects.
All indices of time- and frequency- domain of HRV at M3 were significantly increased when compared with baseline values. CoQ10 improves cardiac function in MVD-affected dogs in first canine study. They report finding that: In a September articlean international team of veterinary cardiologists led by Dr.
Abbott compared the shapes of the mitral valves of 35 young healthy cavalier King Charles spaniels with those of 41 healthy dogs of other breeds mixed, Beagle, and border collieusing three-dimensional echocardiography RT-3DTTE.
Data from our laboratory show that the analysis of canine MV using RT—3DTTE is feasible and repeatable, and that healthy dogs have an elliptical, saddle-shaped MV, with parameters defining this shape similar to those described in healthy humans.
In contrast, dogs affected by MMVD have a more circular and flatter MV, therefore lacking some of the aforementioned favorable geometric characteristics. Based on the results of these studies, we analyzed the MV morphology of healthy CKCSs and compared it to the MV morphology of healthy dogs of other breeds.
They conclude by stating that a longitudinal study is needed to test their hypothesis. Our Cavalier Health Fund already has contributed thousands of dollars to this project and is raising additional funds for it. We deem this research to be one of the most important ones for defeating MVD in our breed.
The ultimate significance of this project would be to be able to predict the future severity of MVD in young CKCS breeding stock by examinging their mitral valves using this 3-D echo technology.
UK cardiologists find MVD-affected cavaliers are more likely to develop pulmonary hypertension than other breeds. All dogs had enlarged hearts due to their MVD.
Researchers devise a treatment plan for MVD-affected dogs in heart failure, based upon natriuretic peptide levels. Twenty-six dogs were in the study, which included five cavalier King Charles spaniels -- the largest number of any breed -- with four examinations over a 21 day period. The dogs were divided into three groups, all three of which were in stable condition based upon routine treatments for CHF e.
No dose adjustments were made to the current treatment. They concluded that the "application of a prespecified treatment escalation algorithm in dogs with recent history and treatment of 1st time CHF secondary to MMVD results in a decrease in plasma NTproBNP concentrations", and that "Use of this treatment escalation algorithm allows effective targeting of treatment for CHF in dogs against an objective criterion.
In sum, this study finds that weekly blood checks for levels of NT-proBNP can allow fine-tuning of the medications which manage MVD-dogs in heart failure. The study is interesting for a couple of reasons, but also seemingly impractical because of the frequency of blood tests required to measure the NT-proBNP levels.
It is interesting because it is another example of human studies being applied to dogs. There is much talk these days about "One Health", especially at PennVet school, which customarily means that what is learned by veterinarians in dogs and cats can be applied to humans.
Here is but another example of where the human medicine came first and then is applied to dogs. A couple of previous veterinary studies have pointed in that direction -- this May abstract and this September article.
The impracticality of this frequency of periodic testing is obvious. Considering that some MVD-afffected dogs in Stage C CHF have been known to survive for a matter of years, this could amount to a very time-consuming and expensive protocol. They primarily were testing the cough-suppression efficacy of alacepril over a period of four weeks.
They report finding that alacepril resolved or lessened the cough in 20 The drug was safe and well tolerated. Alacepril treatment resolved or improved cough in 20 dogs Organ transplant hit an all-time high last year, increasing 27 percent over the previous decade, according to data from the United Network for Organ Sharing.
The group credits the improvement of. We live in a brave new world in which reproductive technologies are ravaging as well as replenishing families. Increasingly common are variations of the situation in which "baby's mother is also grandma-and sister."1 Sometimes extreme measures are necessary in order to have the kind of child we want.
Rewriting Life Surgeons Smash Records with Pig-to-Primate Organ Transplants A biotech company is genetically engineering pigs so that their organs might work in people.
September UK cardiologists find MVD-affected cavaliers are more likely to develop pulmonary hypertension than other vetconnexx.com an April abstract, UK cardiologists Siddharth Sudunagunta and Jo Dukes-McEwan (left) report their study of 94 MVD-affected cavalier King Charles spaniels and 93 MVD-affected non-CKCSs to determine if cavaliers are more likely to develop pulmonary hypertension.
Genetically Engineered Organs November 25, 3 Comments Blog By Genome Compiler Media Team According to Donate Life, another name is added to the national organ transplant waiting list every 10 minutes and an average of 18 people die every day from the lack of available organs for transplant.
Scientists have long struggled to understand why different organs and tissues are affected so differently by mitochondrial mutations. By comparing stem cells with mitochondrial mutations with healthy ones, and coaxing each to develop into different cell types, they can .